BioWorld MedTech

Dec. 4, 2012

Supreme Court limits scope of review of Myriad to eligibility

The Supreme Court has opted to take the Myriad gene patent case, the outcome of which could fundamentally alter how life science companies draft patents for inventions involving genetic materials. Read More

Financings roundup: NanoString completes $15.3M Series E preferred issuance

NeuroMetrix wins FDA clearance for Sensus pain management system

Washington roundup: CMS eyes coverage review for dozens of products, procedures

Report from Europe: Cytomedix reports CE mark appoval for Angel cPRP system

Deals roundup: Volcano to acquire Crux for $36 million in cash

Agreements/contracts: Clinigence combines analytics with Spring Medical Systems

Med-Tech Notes

People in the News

Product Briefs

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for April 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 11, 2025.

FDA clears Dexcom G7 15 Day

BioWorld MedTech

The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...